The Ministry of Health of the Russian Federation in compliance with articles 29 and 32 of the Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product(registration certificate LP-001195 dated November 11, 2011, issued by Ranbaxy Laboratories Limited, India):
Woodist (trade name of the medicinal product)
Stavudine (international non-proprietary, or grouping, or chemical name medicinal product)
capsules, 30 mg, 40 mg (dosage form, dosage)
Ranbaxy Laboratories Limited, India Paonta Sahib, Dist. Sirmour - 173 025, Himachal Pradesh, India (name and address of the place of production)
in connection with the non-confirmation of the state registration of the medicinal product for medical use according to the results of the examination of the relationship between the expected benefit and the possible risk of drug use.